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In the last decade many studies have assessed
the association between daily deaths or hospi-
tal admissions and air pollution, both in
Europe and in the United States (1–12).
Almost all of these studies reported associa-
tions between airborne particles (and some-
times other pollutants) and deaths or hospital
admissions within a few days of exposure, but
they have differed in the exact lag between
exposure and outcome used. They have also
differed in whether they examined only associ-
ations with a 24-hr averaged exposure or con-
sidered effects spread out over several days. 
When studies have considered the possi-
bility of lags or multiday effects, they usually
have used ad hoc approaches based on the
best ﬁt in individual cities, which can be sub-
ject to substantial variability due to stochastic
error. A systematic approach, which used a
multicity analysis to overcome stochastic vari-
ability, would help clarify this situation. This
has recently been applied successfully to the
association between particulate matter ≤ 10
µm (PM10) and mortality (13). Past studies
have traditionally relied on simple moving
averages of pollution to assess the potential
for the effect of air pollution on health to
persist for more than 1 day after exposure.
However, it is quite possible that the effect of
air pollution decreases gradually over several
days, perhaps after ﬁrst rising to a peak. In
that case, a weighted moving average, with
weights that decline to zero after several days,
would be more appropriate than a simple
moving average or single day’s exposure (13). 
It is possible to include air pollution val-
ues on multiple days to directly estimate the
effect of different lags, but this approach is
limited in single-city analyses because multi-
collinearity makes the estimated effects of
different lags very noisy. Although these esti-
mates have large variance, they are unbiased,
and hence a multiple-city analysis, which can
average out the noise, makes this approach
feasible (13). We have applied such a multici-
ty approach to estimate the association
between PM10 and hospital admissions for
heart and lung disease, including the distrib-
ution of effects over time.
A multicity approach estimating the asso-
ciation between air pollution and hospital
admissions has several other advantages. The
National Academy of Sciences has stated that
identifying individuals most sensitive to the
adverse effects of particulate air pollution is a
research priority (14). Multicity analyses
allow us to investigate whether demographic
or economic factors are modifiers of the 
pollution effect. In addition, multicity
approaches provide opportunities to separate
the effect of different air pollutants, analyses
which are of limited utility in single-city
analyses (15). The present analysis examined
distributed lag effects on hospital admissions,
confounding by copollutants, and effect
modiﬁcation by socioeconomic factors in 10
locations from across the United States with
daily measurements of PM10 but widely vary-
ing relationships between PM10 and other
pollutants.
Data and Methods
Data 
To examine the effect of PM10 at multiple
lags, we needed cities with daily PM10 moni-
toring, rather than the more usual 1 day in 6
monitoring schemes. We selected 10 cities
from across the United States that met this
criterion: Canton, Ohio; Birmingham,
Alabama; Chicago, Illinois; Colorado Springs,
Colorado; Detroit, Michigan; Minneapolis/
St. Paul, Minnesota; New Haven,
Connecticut; Pittsburgh, Pennsylvania;
Seattle, Washington; and Spokane,
Washington. We chose the metropolitan
county containing each city, except for
Minneapolis and St. Paul, which were com-
bined and analyzed as one city. We analyzed
daily counts of hospital admissions for cardio-
vascular disease [CVD; International
Classiﬁcation of Disease, 9th revision (ICD-9)
390–429], chronic obstructive pulmonary
disease (COPD; ICD-9 490–496, except
493), and pneumonia (ICD-9 480–487), in
persons ≥ 65 years of age. The data were
extracted from the Health Care Financing
Administration (Medicare; Baltimore, MD)
billing records, which we obtained for the
years 1986–1994. The Medicare system pro-
vides hospital coverage for all U.S. citizens
aged 65 and over.
Daily meteorologic measurements such
as mean temperature, relative humidity, and
barometric pressure, were obtained from the
nearest National Weather Service surface
station for each county (EarthInfo CD
NCDC Surface Airways, EarthInfo Inc.,
Boulder, CO).
Air pollution data for PM10 were
obtained from the U.S. Environmental
Protection Agency’s Aerometric Information
Retrieval System (AIRS) (16). Many of the
cities have more than one monitoring loca-
tion. To ensure that our exposure measure
best represented general population exposure
and not local conditions, monitors within the
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We examined the association between particulate matter ≤ 10 µm; (PM10) and hospital admission
for heart and lung disease in ten U.S. cities. Our three goals were to determine whether there was
an association, to estimate how the association was distributed across various lags between expo-
sure and response, and to examine socioeconomic factors and copollutants as effect modiﬁers and
confounders. We ﬁt a Poisson regression model in each city to allow for city-speciﬁc differences
and then combined the city-specific results. We examined potential confounding by a meta-
regression of the city-speciﬁc results. Using a model that considered simultaneously the effects of
PM10 up to lags of 5 days, we found a 2.5% [95% conﬁdence interval (CI), 1.8–3.3] increase in
chronic obstructive pulmonary disease, a 1.95% (CI, 1.5–2.4) increase in pneumonia, and a
1.27% increase (CI, 1–1.5) in CVD for a 10 µg/m3 increase in PM10. We found similar effect
estimates using the mean of PM10 on the same and previous day, but lower estimates using only
PM10 for a single day. When using only days with PM10 < 50 mg/m3, the effect size increased by
≥ 20% for all three outcomes. These effects are not modiﬁed by poverty rates or minority status.
The results were stable when controlling for confounding by sulfur dioxide, ozone, and carbon
monoxide. These results are consistent with previous epidemiology and recent mechanistic studies
in animals and humans. Key words: air pollution, distributed lag, hierarchical model, hospital
admissions, meta-analysis, meta-regression. Environ Health Perspect 108:1071–1077 (2000).
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among monitors across all counties were
excluded. Some monitors only measure
PM10 1 day in 6, and different monitors have
different means and standard deviations.
Therefore, we needed a scheme for comput-
ing the daily pollution value that did not
change our exposure estimates day to day
because of which monitors reported, as
opposed to differences in actual ambient lev-
els. Thus, the annual mean was computed for
each monitor for each year and subtracted
from the daily values of that monitor. We
then standardized these daily deviances from
each monitor’s annual average by dividing by
the standard deviation for that monitor. The
daily standardized deviations for each moni-
tor on each day were averaged, producing a
daily averaged standardized deviation. We
multiplied this by the standard deviation of
all of the monitor readings for the entire year,
and added back in the annual average of all
of the monitors. This approach has been
described previously (13).
We excluded days when PM10 exceeded
the ambient air quality standard of 150
µg/m3 for the 24-hr mean in order to study
the association at common concentrations.
We also excluded days with hospital admis-
sions outliers, defined as those days with
daily counts more than four times the
interquartile range above the median for
pneumonia and CVD. For COPD, the out-
liers were deﬁned as values that were three
times the interquartile range above the medi-
an, or when the observations were at least
100% higher than the mean of the nearby
data. These can occur for clerical reasons; for
example, records without the date of admis-
sion are coded to the ﬁrst of the month or
year. Alternatively, these outliers may repre-
sent epidemics. This exclusion eliminated a
total of 2 days of data for CVD, 44 days for
pneumonia, and 13 days of data for COPD
in all the 10 cities. The exclusion of these
outliers did not have a marked effect on the
regression coefﬁcients for the PM10 effect.
Methods 
In each city the associations between hospital
admissions and PM10 were investigated with
a generalized additive robust Poisson regres-
sion model (17). In the generalized additive
model, the outcome is assumed to depend on
a sum of nonparametric smooth functions for
each variable. This allows us to better model
the nonlinear dependence of daily admission
on weather and season. The model is of the
form:
log[E(Yt)] = α0+ S1 (X1) + … + Sp (Xp),
where E(Yt) is the expected value of the daily
count of admissions (Yt) and Si are the locally
weighted, running-line, smooth functions
(Loess) of the covariates Xi (18). 
All nonparametric smoothing functions
are characterized by a smoothing parameter,
which determines the smoothness of the ﬁt.
To control for weather variables (24-hr
means of temperature, relative humidity,
and barometric pressure) and day of the
week, we chose the smoothing parameters in
each city that minimized the Akaike’s
Information Criteria (19). 
We chose city-speciﬁc smoothing para-
meters for season, which assure seasonal pat-
terns have been removed, and to minimize
autocorrelation of residuals. In some cases it
was necessary to use autoregressive terms to
eliminate serial correlation (12,20).
PM10 was treated as a linear term in our
analysis to allow examination of how its
effects were distributed over different lags
and to allow the use of meta-analytic tech-
niques to combine results across cities.
It has been argued that there are thresh-
olds for the effects of air pollution and that
no adverse responses occur on most days. To
test this we repeated our analysis, restricting
it to days when PM10 was < 50 µg/m3, which
is one-third of the current U.S. 24-hr mean
national ambient air quality standard (21).
Distributed lag models. Distributed lag
models were introduced by Almon (22) and
have been mainly applied in econometrics
and social sciences. These models allow us to
examine the possibility that air pollution can
influence hospital admissions on the same
day, but also on subsequent days.
The unconstrained distributed lag model
of order q is
log[E(Yt)] = α + covariates + β0Zt
+ β1Zt–1 + . . . + βqZt–q. [1]
Hence, the outcome Yt at time t may depend
on the exposure (Zt) measured not only on
the current day but also on previous days.
The overall impact of a unit change in expo-
sure on one day is the sum of its impact on
that day and its impacts on subsequent days
(i.e., β0 + β1 + . . . + βq). The problem is
that Zt is correlated with Zt–1, … , Zt–q and
the high degree of collinearity will result in
unstable estimates of the βj. However, both
the βj and the sum of all βj will be unbiased
estimators of the effects at each lag and of
the overall effects. Because they are unbiased,
combining results across cities will produce
more stable unbiased estimates.
A 1-day exposure model can be seen as a
constrained model, where βj =0  for
j =1…q. If we have no strong biological
reason for that constraint, it is preferable to
let the data tell us what the actual pattern
looks like. While the 1-day model may be an
unreasonably strong constraint, which risks
introducing bias, a more ﬂexible constraint
may reduce the variance of the individual β
with less risk of bias. One common approach
is to constrain the β values to follow a ﬂexible
polynomial (13,23–25). 
We have used the unconstrained model
as our primary approach, relying on the
combined results across cities to cancel out
noise and provide stable estimates. We used
quadratic distributed lag models as a sensi-
tivity analysis. In both cases we estimated
lags of up to 5 days between exposure and
hospitalization. For comparison to previous
results, we estimated the effect of PM10 on
the same day, and on the mean of the same
and previous day as exposure variables.
Hierarchical modeling. Hierarchical
modeling is a multistage approach in which a
set of models are ﬁt in (in our case) individ-
ual cities, and the results of those regressions
are analyzed in a second-stage regression to
examine issues of effect modification and
confounding (26). In the second stage of the
analysis we first used inverse–variance-
weighted averages to combine results across
cities. These were computed for both the
estimated overall effect (the sum of the βi)
and for the effect of each lag. More formally,
we assumed the effect of PM10 in city i
(i = 1–10) was β ˆ
i ~ N(µ,V), and we estimat-
ed µ from the 10 city-speciﬁc β ˆ
i values and
their variances by computing an inverse–
variance-weighted average. We then extend-
ed this approach to a full second-stage
regression. To examine effect modification
by socioeconomic status, for example, we ﬁt
a weighted, least-squares regression: 
β ˆ
i = β* + δPi + εi, [2]
where β ˆ
i is the estimated PM10 effect in city
i, Pi is the socioeconomic index in that city,
and, again, inverse variance weighting is
done. The variable δ then tells us how much
the effect of PM10 changes for a unit
increase in the social index. We examined
the percentage of the population living
below the federal poverty level and the per-
centage of the population that was nonwhite
as potential modiﬁers of the effect of PM10
on hospital admissions of the elderly. 
Confounding is usually examined by
including potential confounders in what is
here the ﬁrst stage of a hierarchical regression
model. However, because weather tends to
increase or decrease all pollutants in parallel,
that approach risks substantial collinearity
problems. Although most pollutants increase
and decrease together, the incremental
increase in one pollutant (in micrograms per
cubic meter) that is associated with each
microgram per cubic meter increase in
another pollutant varies substantially across
locations. We have used this variation to
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our analysis.
To illustrate this approach, suppose the
true association is between our outcome and
pollutant X1:
Y = β0 + β1 X1 + εt. [3]
Assume X1 is correlated with another
pollutant, X2, that is not causal for Y. It is
possible to quantify the association between
them by
X1 = γ0 + γ1X2 + εt. [4]
Substituting Equation 4 in Equation 3 it
follows that:
Y = β0 + β1γ0 + β1γ1X2 + εt, 
and we see that the induced coefﬁcient for
the noncausal variable X2 depends on γ1, the
slope of the relationship between X1 and X2.
From this, we can see that it is natural to
extend our meta-regression approach to use
the slope between pollutants as an explanato-
ry factor in the second-stage model. That is, 
β ˆ
i * = β* + δγi + εi
where γi is the slope between SO2 and PM10,
for example. β*, the intercept term in this
regression, is the estimated effect of PM10 in
a city where it had no correlation with SO2.
This is the unconfounded effect of PM10.
This approach has recently been applied to
mortality data (27).
Simulation study. To test the power of
our two-stage approach to detect confound-
ing, we did a simulation study. We simulated
the case where one pollutant was really stand-
ing for another, and looked to see whether the
association with the noncausal pollutant disap-
peared in our two-stage approach. Speciﬁcally,
we examined a scenario where analyses were
done in 10 cities, with 2,000 days of data in
each location. This is somewhat fewer data
than we have. In each location, we generated
two exposure variables that were multivariate
normal, with a correlation coefﬁcient of 0.70.
However, the regression coefﬁcient between
the two pollutants was chosen from a uniform
distribution with a 3-fold variation in slopes.
This is less variation than is present in the
actual data we were analyzing.
We then generated a random Poisson
count with a log relative risk for one pollu-
tant of 0.05, and no true association with
the other pollutant. We ﬁt a Poisson regres-
sion in each of the 10 locations and estimat-
ed the regression coefﬁcient of the noncausal
pollutant in each location. Then we
regressed those 10 coefﬁcients against the 10
slopes relating the two pollutants and took
the intercept term in that regression as the
estimate of the nonconfounded effect of the
noncausal pollutant. We repeated this 500
times and looked at the median and 95%
conﬁdence interval for the noncausal pollu-
tant to see if they were centered on zero and
with magnitude that would clearly distinguish
them from 0.05.
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Table 1. 25th, 50th, and 75th percentile values for the environmental variables in the 10 cities.
Temperature Relative Barometric PM10
City Date of study (°F) humidity pressure (µg/m3)
Akron 1 Jan 1989–24 Dec 1994 36 66 28.6 19
51 74 28.8 26
66 82 28.9 34
Birmingham 1 Apr 1987–31 Dec 1993 51 62 29.3 20
65 71 29.4 31
76 80 29.5 46
Chicago 1 Mar 1988–24 Dec 1994 35 62 29.2 23
51 70 29.3 33
67 79 29.4 46
Colorado Springs 1 Jul 1987–24 Dec 1994 36 39 23.9 18
51 51 24.0 23
64 66 24.1 31
Detroit 1 May 1986–24 Dec 1994 36 64 29.2 21
52 71 29.3 32
67 79 29.4 49
Minneapolis 1 Apr 1987–24 Dec 1994 31 60 29.0 17
49 69 29.1 24
67 78 29.2 35
New Haven 1 May 1987–31 Dec 1991 38 57 29.7 17
53 67 29.8 26
68 77 30.0 38
Pittsburgh 1 Jan 1987–24 Dec 1994 37 61 28.6 19
53 70 28.8 30
68 79 28.9 47
Seattle 1 Jan 1986–24 Dec 1994 45 67 29.5 18
52 77 29.6 27
60 85 29.7 39
Spokane 1 Oct 1985–24 Dec 1994 35 49 27.4 23
47 68 27.5 36
61 84 27.7 57
Table 2. Population and 25th, 50th, and 75th percentile values for the daily counts of hospital admissions for
CVD, COPD, and pneumonia in the 10 cities.
Population
City (≥ 65 years of age) CVD COPD Pneumonia
Canton 52,900 7 0 1
912
12 2 3
Birmingham 119,000 14 1 3
17 1 5
21 2 7
Chicago 633,000 86 4 20
103 7 25
117 11 31
Colorado Springs 31,700 2 0 0
301
412
Detroit 263,900 41 2 7
50 4 10
59 6 13
Minneapolis/St. Paul 176,000 13 1 3
16 1 5
20 3 7
New Haven 118,200 12 0 2
16 1 4
20 1 5
Pittsburgh 232,500 38 3 7
48 5 10
56 8 13
Seattle 167,300 13 1 3
17 1 4
20 2 6
Spokane 48,000 4 0 1
611
713Results
Table 1 shows the 25th, 50th, and 75th per-
centiles of each of the variables used in the
analysis in each city. Colorado Springs had
the lowest median PM10 concentration, and
Spokane had the highest. Table 1 also shows
the dates during which daily PM10 measure-
ments were available in each city. Table 2
presents the population ≥ 65 years of age and
the percentile values for the hospital admis-
sions data. Table 3 shows the correlation
between PM10 and the weather variables.
The correlations were always modest and, for
temperature and barometric pressure, include
both positive and negative correlations. In
one city (Spokane) PM10 was essentially
uncorrelated with temperature. 
Overall effects of PM10. Table 4 shows
the combined overall estimate for the con-
strained (1-day mean, 2-day mean, quadratic
distributed lag) and the unconstrained dis-
tributed lag model, for a 10 µg/m3 increase
in PM10. The effect size estimate for the 2-
day mean and the quadratic distributed lag
are similar to the effect estimate using the
unconstrained model, and all three are
always higher than the 1-day lag. When the
analysis using the 2-day mean of PM10 was
repeated using only days with PM10 < 50
µg/m3, the effect size increased by ≥ 20% for
all three outcomes.
Distributed lag over time. Figures 1–3
show the combined city estimate of the
unconstrained distributed lag association
between PM10 and the three analyzed causes
of admissions. For COPD admissions
(Figure 1) the effect is similar for PM10 on
the concurrent day and the previous day and
goes to near zero at lag 2 and subsequent
days. For pneumonia admissions (Figure 2)
the effect decreases continuously for lags 0–2
and then oscillates about zero for further
lags. Cardiovascular admissions (Figure 3)
show a higher effect at lag 0, dropping to a
more modest effect at lags 1 and 2, and then
oscillate about zero. 
Second-Stage Models
Social factors. Neither the percentage of the
population living in poverty nor the percent-
age of the population that was nonwhite was
a signiﬁcant modiﬁer of the PM10 slopes in
our cities. Table 5 shows the change from
the baseline PM10 effect size (as percent
increase in admission per 10 µg/m3 increase
in concentration) associated with a 5-point
increase in the percentage of the population
living below the federal poverty level or the
percentage of the population that is not
white.
Copollutants. Figures 4 and 5 show the
data for of the meta-regression. Figure 4
shows, for COPD and pneumonia, the
effect of PM10 in each city plotted against
the regression coefﬁcients relating SO2 and
ozone to PM10 in each city. Figure 5
presents the CVD results, where we consid-
ered also the regression coefficients of CO
versus PM10.
These plots give an idea of the range of
the results by city. These vary from a nega-
tive effect to effects higher than a 6%
increase for 10 µg/m3 PM10 for COPD or
pneumonia, while for CVD the higher
effects are around 2%. They also show the
range of regression coefﬁcients relating PM10
to the other pollutants. For O3 they include
both positive and negative slopes and vary
considerably within each sign, with a wider
range among the positive slopes. For SO2
and CO the slopes are always positive, but
vary by almost an order of magnitude.
As explained in “Methods,” if the PM10
effect were due to confounding with other
pollutants, the plots would show a signifi-
cantly increasing trend with increasing slope
between the pollutants. Figures 4 and 5 show
little evidence of such a pattern. These results
are confirmed by the meta-regression esti-
mates, shown in Figure 6. Here the baseline
estimate is the result of the distributed lag
meta-analysis. Plotted above each pollutant
is the estimated intercept in the meta-regres-
sion of the PM10 coefficients against the
slopes between that copollutant and PM10.
For all three outcomes the results appear
quite stable to control for confounding by
gaseous pollutants. Moreover, there are no
consistent patterns indicative of confound-
ing. For example, the effect of PM10 on
pneumonia admissions increases somewhat
after control for SO2 and decreases after con-
trol for O3; for COPD the pattern is the
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Table 3. Correlation between PM10 and other
environmental variables in the 10 cities.
Temp Barometric
City (°F) RH pressure
Canton 0.42 –0.16 0.15
Birmingham 0.26 –0.3 0.12
Chicago 0.36 –0.3 –0.02
Colorado Springs –0.34 –0.11 –0.01
Detroit 0.37 –0.14 –0.05
Minneapolis/St. Paul 0.29 –0.35 –0.03
New Haven 0.05 –0.15 0.11
Pittsburgh 0.45 –0.23 0.14
Seattle –0.22 –0.11 0.24
Spokane –0.01 –0.19 0.16
Abbreviations: RH, relative humidity; Temp, temperature. 
Table 4. Results of the combined analysis: percentage increase in admissions for a 10 µg/m3 increase in
PM10 in 10 U.S. cities. 
COPD Pneumonia CVD
Model Percent SE Percent SE Percent SE
Constrained lag
1-Day meana 1.48 0.23 1.57 0.15 1.09 0.08
2-Day meanb 2.04 0.25 2.03 0.17 1.21 0.08
PM10 < 50 µg/m3 (2-day mean)b 2.41 0.47 2.96 0.33 1.51 0.15
Quadratic distributed lag 2.56 0.36 1.73 0.22 1.22 0.11
Unconstrained distributed lag 2.54 0.36 1.95 0.23 1.27 0.11
aLag 0. bMean of lag 0 and lag 1.
Figure 1. The combined city estimate of the
unconstrained distributed lag between air pollu-
tion and COPD admissions. CL, conﬁdence limits.
The effect size plotted is the percent increase for
a 10 µg/m3 increase in PM10. 
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Figure 2. The combined city estimate of the uncon-
strained distributed lag between air pollution and
pneumonia. CL, conﬁdence limits. The effect size
plotted is the percent increase for a 10 µg/m3
increase in PM10.
Figure 3. The combined city estimate of the uncon-
strained distributed lag between air pollution and
CVD. CL, conﬁdence limits. The effect size plotted
is the percent increase for a 10 µg/m3 increase in
PM10. 
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niﬁcant predictor of the PM10 slope.
Weather variables. The wide range of
weather patterns, shown in Table 3, give
considerable support to the conclusion that
these results are not confounded by inade-
quate control for weather. Figure 7, plotting
the effect size estimates for the distributed
lag PM10 versus the correlation of PM10
with temperature and relative humidity,
shows similar effects sizes across a broad
range of correlations. Hence, these results are
unlikely to be confounded by weather. In
the formal meta-regression we found that
the coefﬁcient for temperature was not sig-
niﬁcant for all the three outcomes, but for
relative humidity we found some negative
confounding with COPD. The effect size of
PM10 is not modified by temperature; the
percentage increase of 10 µg/m3 of PM10 is
1.2% for CVD (SE = 0.2); 3.3% for COPD
(SE = 0.7), and 2.1% for pneumonia
(SE = 0.5). There is no effect modification
due to relative humidity for CVD (1.8%;
SE = 0.4) and for pneumonia (1.7%;
SE = 1.1), while the PM10 effect increased
for COPD with a 5.5% increase (SE = 1.2).
Simulation. The 95% conﬁdence interval
for the slopes between the two simulated pol-
lutants ranged from 0.48 to 1.27, reﬂecting
the 3-fold range that was our target. In the
meta-regression, the intercept term was taken
as the non-confounded effect of the non-
causal pollutant, as in our analysis of real
data. The median estimate for this was
–0.00008, and the 95% conﬁdence interval
was –0.0098–0.0102. This demonstrates that
our approach has the power to detect signiﬁ-
cant confounding in a 10-cities study, with a
smaller range of variation in pollutant–pollu-
tant slopes than was seen in the study.
Discussion
There are four main ﬁndings of this study.
First, PM10 is associated with increased hospi-
tal admissions for CVD, COPD, and pneu-
monia. Second, the effect of a 24-hr increase
in PM10 is spread over that day and several
subsequent days, and single-day analyses
underestimate the impact of PM10. Third,
these effects are not modiﬁed by poverty rates
or minority status and are relatively stable to
control for potential confounding by SO2,
O3, and CO. And fourth, these effects persist
at common concentrations well below the
current air quality standards. We discuss each
of these ﬁndings in turn. 
The ﬁnding that airborne particles are asso-
ciated with hospital admissions for heart and
lung disease has been reported in many other
studies. In general, the effect-size estimate
reported here is consistent with those previous
studies. The advantage of this study is that it
involves more years of follow-up than most
previous studies and 10 cities spread across the
continent, with a wide range of coincident
weather and copollutants. 
For all three outcomes, the effect of
PM10 appears to be spread over more than 1
day, and Table 4 shows that the use of a sin-
gle exposure day will underestimate the
effect of PM10, sometimes by a substantial
factor. This suggests that integrative sum-
maries of the health data need to address this
issue. Most studies of air pollution have used
multiday averages but some have not, and
this will need to be taken into account in
any future meta-analysis. A recent analysis of
daily deaths in these same cities found the
use of a single day’s exposure underestimated
the effect of PM10 on daily deaths by more
than a factor of 2, for instance (13).
Confounding by gaseous pollutants has
been raised as a major issue regarding previ-
ous studies (28). We found that the effect-size
estimate for PM10 and hospital admissions for
CVD, COPD, and pneumonia changed little
after control for potential confounding by
gaseous air pollutants in our second-stage
regression. The standard errors increased
because our second-stage analysis had a limit-
ed sample size (10 points in a regression esti-
mating an intercept and a slope), but overall
the evidence for confounding was small.
Temperature did not appear to confound the
PM10 association either, whereas for relative
humidity there seemed to be some negative
confounding for COPD admissions.
We have not found evidence that obvi-
ous socioeconomic factors such as poverty
and race are modiﬁers of these effects. There
may be several reasons for this. First, it is
important to realize that Poisson models are
relative risk models. They have multiplicativ-
ity built in. That is, a given change in PM10
is associated with a given percent increase in
admissions. If a town with more poverty or
larger percentage of nonwhites has a higher
baseline rate of admission, then a 3%
increase in the admissions rate from baseline
Articles • Airborne particles and hospital admissions
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Table 5. Effect modiﬁcation by percentages of the
population living in poverty or nonwhite. 
Poverty Nonwhite
Disease % (95% CI) % (95% CI)
CVD 0.15 (–0.19–0.50) 0.06 (–0.03–0.15)
COPD –0.71 (–1.95–0.55) –0.21 (–0.53–0.11)
Pneumonia –0.53 (–1.34–0.29) –0.05 (–0.28–0.18)
Results are shown for a 10 µg/m3 increase in PM10 and a
5 percentage point increase in the effect modiﬁers.
Figure 4. The effect of PM10 on COPD and pneumonia in each city plotted against the regression coefﬁcients
relating SO2 and O3 to PM10.
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Figure 5. The effect of PM10 on cardiovascular admissions in each city plotted against the regression
coefﬁcients relating SO2, CO, and O3 to PM10.
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–1will be a greater increase (per 10,000 persons
≥ 65 years of age) in that town than in a
town with a lower baseline rate.
It may be that the medical conditions that
predispose to higher risk are not well captured
by these socioeconomic factors and that more
speciﬁc medical conditions, rather than social
factors, are needed to explore effect modiﬁca-
tion. Finally, we used county-level data for
these social factors because our admissions
data are on that level. But the variation in
socioeconomic status within the typical urban
county is usually considerably larger than the
variation across counties. Our social factors
may be too ecologic to be meaningful. In this
case, future studies using ﬁner geographical
data may be able to ﬁnd some modiﬁcation.
If these associations are causal, as we have
argued, then it is crucial for public health
impact assessment to know whether the asso-
ciations are dominated by only a few high
pollution days or whether they persist at the
concentrations seen on most days. When we
restricted our analysis to days with concen-
trations of one-third of current air quality
standard or less (< 50 µg/m3), we still found
a signiﬁcant association between PM10 and
admissions for all three illnesses. Moreover,
the effect size increased by 20% or more.
This increase in effect size at lower concen-
trations has been noted previously in a mor-
tality study (6). For a signiﬁcant association
to persist, and grow in size, on days with lev-
els < 50 µg/m3, any threshold would have to
be far below that level, and likely down to
background levels. The more likely scenario
is that the true concentration–response curve
is curvilinear, with higher slopes at lower
concentrations and no threshold.
In addition to this statistical evidence,
there has been a substantial increase in 
evidence for the biological plausibility of
these effects. Recent studies have reported
that particulate air pollution is associated
with reduced heart rate variability and
increased fibrinogen levels in animals
(29–31). These are known risk factors for
arrhythmia and ischemic events, which are
the major sources of hospital admissions for
heart disease. Human studies have reported
airborne particles associated with increased
plasma viscosity (32) and decreased heart rate
variability (33–35), paralleling animal stud-
ies. Airborne particles  have also been associ-
ated with increased fibrinogen and platelet
levels in humans (36); and they are associated
with increased heart rate (37,38). These
changes in risk factors for arrhythmia are
supported by a recent study of patients with
implanted cardiac deﬁbrillators. Deﬁbrillator
discharges to halt arrhythmic events were
associated with particulate air pollution and
NO2 (39). Further, the increase in mortality
associated with airborne particles was particu-
larly strong for sudden death (40), which is
again consistent with these recent animal and
human results. 
Animals with COPD or chronic lung
inflammation have been shown to have
increased vulnerability to combustion parti-
cles (41–44). And exposure to concentrated
air particles of animals previously infected
with strep pneumonia resulted in a doubling
of lung area involved with pneumonia, and
of bacterial burdens (45). Inﬂuenza infections
have similarly been shown to be exacerbated
by air pollution (46).
Given the consistent epidemiologic evi-
dence, the indications of little, if any, con-
founding by gaseous copollutants and
weather, the mechanistic animal studies
showing airborne particles can exacerbate
these illnesses, and the more recent mecha-
nistic human studies, we believe that there is
a strong case for causal associations between
PM10 and heart and lung diseases.
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